Jenscare Scientific Reports Reduced Losses and Advances in Valve Replacement Technology

Jenscare Scientific Co. Ltd. Class H ( (HK:9877) ) just unveiled an update.

Jenscare Scientific Co., Ltd. announced a significant reduction in its annual losses for 2024, with a 51% decrease in loss before income tax compared to the previous year. The company is actively commercializing its Ken-Valve product following recent regulatory approvals, while its LuX-Valve Plus has shown promising clinical results, reinforcing its competitive position in the global market.

More about Jenscare Scientific Co. Ltd. Class H

Jenscare Scientific Co., Ltd. is a joint stock company incorporated in China, focusing on the medical device industry. The company specializes in transcatheter valve replacement products, including the LuX-Valve series for tricuspid valve replacement and Ken-Valve for aortic valve replacement, aiming to expand its global market presence.

YTD Price Performance: 29.66%

Average Trading Volume: 207,010

Technical Sentiment Consensus Rating: Hold

Current Market Cap: HK$2.47B

For an in-depth examination of 9877 stock, go to TipRanks’ Stock Analysis page.